Search
for
Sort by
Research 30 of 506
- Anticonvulsant hypocalcaemia.
- Balding man.
- Self-medication by Jockeys
- Drug-Induced Skin, Nail and Hair Disorders
- Male fertility and skin diseases
- Men??s Health
- Lab Quality Management and Methodology
- Interventions for morphea
- Expert consensus on the management of telogen effluvium in India
- Non‐biologic immunosuppressive drugs for inflammatory and autoimmune skin diseases
- Medical Dermatology
- Anticonvulsant Activity of Progesterone and Neurosteroids in Progesterone Receptor Knockout Mice
- Effects of anticonvulsant drugs on chromosomes.
- Anticonvulsant-Induced Cutaneous Reactions
- Alopecia Areata Universalis After Phenobarbital-Induced Anti-Convulsant Hypersensitivity Syndrome
- The anticonvulsant effects of progesterone and its metabolites
- Role of Anticonvulsant and Antiepileptogenic Neurosteroids in the Pathophysiology and Treatment of Epilepsy
- The Acute Anticonvulsant Effects of Deoxycorticosterone in Developing Rats: Role of Metabolites and Mineralocorticoid‐receptor Responses
- Deoxycorticosterone’s anticonvulsant effects in infant rats are blocked by finasteride, but not by indomethacin
- Progesterone and its Metabolites: Anticonvulsant and Behavioral Studies
- Finasteride, a 5alpha-reductase inhibitor, blocks the anticonvulsant activity of progesterone in mice.
- Role of neurosteroids in the anticonvulsant activity of midazolam
- Valproic acid (Depakene). A new anticonvulsant agent
- Evaluating the Metabolomic Profile and Anti-Pathogenic Properties of Cannabis Species
- 5. Novel anticonvulsant effects of supraphysiological doses of progesterone in hippocampal-kindled mice
- The prevalence and management of side effects of lithium and anticonvulsants as mood stabilizers in bipolar disorder from a clinical perspective
- Sodium valproate and thrombocytopenia.
- Psychological interventions in the management of common skin conditions
- Psychotropic Medication and Drug-Related Alopecia
- Valproic acid reduces hair loss and improves survival in patients receiving temozolomide-based radiation therapy for high-grade glioma